QIAGEN reported strong performance in Q2 2025 with solid sales growth and increased profitability, driven by key growth pillars. The company upgraded its full-year sales outlook and demonstrated effective cash flow management and shareholder returns. However, challenges were noted in the Asia Pacific region and flat sales in sample technologies.

Company Guidance -

Q3 2025

In the Q2 2025 earnings call, QIAGEN announced a strong financial performance and increased its full-year sales outlook. The company reported net sales growth of 7% to $534 million, with a 6% growth at constant exchange rates. Core sales, excluding discontinued products like NeuMoDx and DIALUNOX, also rose by 6% CER. Adjusted diluted EPS stood at $0.60, or $0.62 at CER, surpassing targets due to operational profitability improvements. QIAGEN's growth pillars, including QIAstat and QuantiFERON, contributed significantly with QIAstat achieving 41% CER growth and QuantiFERON growing 11% CER. The company revised its full-year '25 net sales growth outlook to 4%-5% at CER and confirmed its adjusted EPS target of $2.35 at CER. Moreover, QIAGEN highlighted its commitment to shareholder value through dividends and share repurchases, while continuing to invest in innovation and strategic M&A opportunities.

Solid Sales Growth

Net sales rose 7% to $534 million with a 6% growth at constant exchange rates, exceeding the company’s outlook for Q2 2025.

Strong Performance in Key Growth Pillars

QIAstat grew 41% at CER, QuantiFERON grew 11% CER, and QIAcuity delivered double-digit CER growth, driven by strong demand and strategic initiatives.

Increased Full Year Sales Outlook

QIAGEN upgraded its full year '25 sales outlook to 4% to 5% net sales growth at constant exchange rates, up from the previous target of about 4% growth.

Improved Profitability

Adjusted operating income margin rose to 29.9% of sales, up 1.5 percentage points from the same quarter last year, driven by efficiency initiatives.

Strong Cash Flow and Shareholder Returns

Generated $301 million in operating cash flow, returned over $350 million to shareholders through share repurchase and dividend payments.

Qiagen (QGEN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

QGEN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 04, 2025	2025 (Q3)	0.59 / -	0.586	―	―	―
Aug 05, 2025	2025 (Q2)	0.60 / 0.60	0.566	6.01% (+0.03)
May 07, 2025	2025 (Q1)	0.50 / 0.55	0.473	16.28% (+0.08)
Feb 05, 2025	2024 (Q4)	0.62 / 0.61	0.566	7.77% (+0.04)
Nov 06, 2024	2024 (Q3)	0.56 / 0.59	0.53	10.57% (+0.06)
Jul 31, 2024	2024 (Q2)	0.54 / 0.57	0.541	4.62% (+0.02)
Apr 29, 2024	2024 (Q1)	0.45 / 0.47	0.541	-12.57% (-0.07)
Feb 06, 2024	2023 (Q4)	0.57 / 0.57	0.562	0.71% (<+0.01)
Oct 30, 2023	2023 (Q3)	0.51 / 0.53	0.562	-5.69% (-0.03)
Aug 08, 2023	2023 (Q2)	0.53 / 0.54	0.541	0.00% (0.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

QGEN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$49.95	$47.49	-4.92%
May 07, 2025	$42.41	$41.94	-1.11%
Feb 05, 2025	$43.57	$42.22	-3.10%
Nov 06, 2024	$43.64	$43.91	+0.62%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Qiagen NV (QGEN) report earnings?

Qiagen NV (QGEN) is schdueled to report earning on Nov 04, 2025, After Close (Confirmed).

What is Qiagen NV (QGEN) earnings time?

Qiagen NV (QGEN) earnings time is at Nov 04, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is QGEN EPS forecast?

QGEN EPS forecast for the fiscal quarter 2025 (Q3) is 0.59.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing